Joan de Jong

1.8k total citations
12 papers, 1.5k citations indexed

About

Joan de Jong is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Joan de Jong has authored 12 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Joan de Jong's work include Immune Response and Inflammation (5 papers), Immunotherapy and Immune Responses (4 papers) and T-cell and B-cell Immunology (4 papers). Joan de Jong is often cited by papers focused on Immune Response and Inflammation (5 papers), Immunotherapy and Immune Responses (4 papers) and T-cell and B-cell Immunology (4 papers). Joan de Jong collaborates with scholars based in Netherlands, Spain and United States. Joan de Jong's co-authors include Jan Paul Medema, Rienk Offringa, Michael Hahne, Thorbald van Hall, Cornelis J.M. Melief, Carla Eponina Carvalho-Pinto, Carlos Martı́nez-A, Cornelis J.M. Melief, Marta López‐Fraga and Dolores Rodrı́guez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Joan de Jong

12 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan de Jong Netherlands 10 1.0k 494 372 203 188 12 1.5k
Vanessa L. Bryant Australia 17 1.3k 1.3× 341 0.7× 314 0.8× 144 0.7× 187 1.0× 33 1.8k
Joseph R. Tumang United States 25 1.5k 1.5× 461 0.9× 324 0.9× 332 1.6× 119 0.6× 37 2.1k
Agnès Moreau‐Aubry France 17 806 0.8× 448 0.9× 433 1.2× 88 0.4× 131 0.7× 30 1.3k
Birgit Knoechel United States 20 1.1k 1.1× 557 1.1× 384 1.0× 135 0.7× 106 0.6× 31 2.0k
Marie‐Claude Stolzenberg France 16 1.1k 1.1× 551 1.1× 309 0.8× 87 0.4× 132 0.7× 25 1.5k
Nadine Taubenheim Australia 13 702 0.7× 836 1.7× 324 0.9× 102 0.5× 140 0.7× 14 1.6k
Mohammad Zafari United States 16 1.5k 1.5× 506 1.0× 348 0.9× 269 1.3× 102 0.5× 29 2.0k
Mark Klinger United States 18 872 0.9× 504 1.0× 696 1.9× 200 1.0× 88 0.5× 30 1.7k
Sandra Gardam Australia 15 1.6k 1.5× 379 0.8× 217 0.6× 433 2.1× 127 0.7× 18 2.1k
Claudia Bossen United States 14 1.4k 1.3× 924 1.9× 272 0.7× 220 1.1× 102 0.5× 20 2.2k

Countries citing papers authored by Joan de Jong

Since Specialization
Citations

This map shows the geographic impact of Joan de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan de Jong more than expected).

Fields of papers citing papers by Joan de Jong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan de Jong. The network helps show where Joan de Jong may publish in the future.

Co-authorship network of co-authors of Joan de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Joan de Jong. A scholar is included among the top collaborators of Joan de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan de Jong. Joan de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Hoorn, Sanne ten, Anne Trinh, Joan de Jong, Lianne Koens, & Louis Vermeulen. (2018). Classification of Colorectal Cancer in Molecular Subtypes by Immunohistochemistry. Methods in molecular biology. 1765. 179–191. 35 indexed citations
2.
Bergen, Cornelis A.M. van, Els M.E. Verdegaal, Joan de Jong, et al.. (2014). Durable Remission of Renal Cell Carcinoma in Conjuncture with Graft versus Host Disease following Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion: Rule or Exception?. PLoS ONE. 9(1). e85198–e85198. 4 indexed citations
3.
Hende, Muriel van den, Mariëtte I.E. van Poelgeest, Jeanette M. van der Hulst, et al.. (2008). Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia. International Journal of Cancer. 123(1). 146–152. 34 indexed citations
4.
Planelles, Lourdes, Carla Eponina Carvalho-Pinto, Gijs Hardenberg, et al.. (2004). APRIL promotes B-1 cell-associated neoplasm. Cancer Cell. 6(4). 399–408. 117 indexed citations
5.
Stein, Jens V., Marta López‐Fraga, Carla Eponina Carvalho-Pinto, et al.. (2002). APRIL modulates B and T cell immunity. Journal of Clinical Investigation. 109(12). 1587–1598. 223 indexed citations
6.
Stein, Jens V., Marta López‐Fraga, Carla Eponina Carvalho-Pinto, et al.. (2002). APRIL modulates B and T cell immunity. Journal of Clinical Investigation. 109(12). 1587–1598. 203 indexed citations
7.
Stein, Jens V., Marta López‐Fraga, Carla Eponina Carvalho-Pinto, et al.. (2002). APRIL modulates B and T cell immunity. Journal of Clinical Investigation. 109(12). 1587–1598. 12 indexed citations
8.
Burg, Sjoerd H. van der, Maaike E. Ressing, Kitty M.C. Kwappenberg, et al.. (2001). Natural T-helper immunity against human papillomavirus type 16 (hpv16) e7-derived peptide epitopes in patients with hpv16-positive cervical lesions: Identification of 3 human leukocyte antigen class ii-restricted epitopes. International Journal of Cancer. 91(5). 612–618. 125 indexed citations
9.
Medema, Jan Paul, Danita H. Schuurhuis, Delphine Réa, et al.. (2001). Expression of the Serpin Serine Protease Inhibitor 6 Protects Dendritic Cells from Cytotoxic T Lymphocyte–Induced Apoptosis. The Journal of Experimental Medicine. 194(5). 657–668. 175 indexed citations
10.
Medema, Jan Paul, Joan de Jong, Lucy T.C. Peltenburg, et al.. (2001). Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proceedings of the National Academy of Sciences. 98(20). 11515–11520. 277 indexed citations
11.
Medema, Jan Paul, Joan de Jong, Thorbald van Hall, Cornelis J.M. Melief, & Rienk Offringa. (1999). Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein. The Journal of Experimental Medicine. 190(7). 1033–1038. 280 indexed citations
12.
Jong, Joan de, et al.. (1992). Direct Gold-Silver Method for HCG Binding to Specific Tissue Structures. Journal of Histotechnology. 15(4). 275–281. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026